{"brief_title": "A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection", "brief_summary": "To investigate the appropriate zalcitabine ( dideoxycytidine; ddC ) dose and zidovudine ( AZT ) schedule for use in combination therapy in patients with HIV infection.", "detailed_description": "Patients are randomized to one of four treatment arms. ddC is administered at 1 of 2 doses every 8 hours. AZT is administered at 1 of 2 doses (every 4 hours while awake or every 8 hours).", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Zalcitabine", "criteria": "Inclusion Criteria Patients must have: - HIV infection. - CD4 count 100 - 500 cells/mm3.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00002117.xml"}